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Viral Gene Delivery Selectively Restores
Feeding and Prevents Lethality
of Dopamine-Deficient Mice
of the nigrostriatal pathway with symptoms becoming
apparent when DA concentrations fall below z20% of
normal levels (Hornykiewicz, 1966). Reward-related be-
haviors appear to involve the mesolimbic dopaminergic
system, which is comprised of the group A10 dopamin-
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tures, including the nucleus accumbens (NAc) andSeattle, Washington 98195
amygdala (Dahlstrom and Fuxe, 1964; Lindvall and²Cell Genesys Inc.
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DA is released in the NAc when animals perform tasksFoster City, California 94404
that are postulated to be rewarding. For example, extra-
cellular dopamine is detected in this brain region when
rodents self-administer drugs such as cocaine and am-Summary
phetamine (Hurd et al., 1989; Pontieri et al., 1995).
DA is also released in the NAc and amygdala whenDopamine-deficient mice (DA2/2), lacking tyrosine hy-
food-deprived animals are given a palatable meal, anddroxylase (TH) in dopaminergic neurons, become hy-
bilateral injection of DA into the NAc can stimulate feed-poactive and aphagic and die by 4 weeks of age. They
ing (Martel and Fantino, 1996a; Hajnal and Lenard, 1997;are rescued by daily treatment with L-3,4-dihydroxy-
Swanson et al., 1997; Taber and Fibiger, 1997). In addi-phenylalanine (L-DOPA); each dose restores dopamine
tion, bilateral 6-OHDA lesions of midbrain dopaminergic(DA) and feeding for less than 24 hr. Recombinant
neurons results in aphagia, and complete removal of DAadeno-associated viruses expressing human TH or
from dopaminergic neurons abolishes ingestive behav-GTP cyclohydrolase 1 (GTPCH1) were injected into the
iors (Ungerstedt, 1971; Zhou and Palmiter, 1995). Thus,striatum of DA2/2 mice. Bilateral coinjection of both
there are strong indications that DA is necessary forviruses restored feeding behavior for several months.
feeding, but the neural pathways involved are not estab-However, locomotor activity and coordination were
lished. Furthermore, the effects of DA depletions onpartially improved. A virus expressing only TH was
feeding behavior could be nonspecific because DA sig-less effective, and one expressing GTPCH1 alone was
naling impinges on many brain functions (Salamone etineffective. TH immunoreactivity and DA were de-
al., 1990).tected in the ventral striatum and adjacent posterior
We used gene-targeting techniques to generate DA2/2regions of rescued mice, suggesting that these re-
mice that cannot synthesize TH, the initial, rate-limitinggions mediate a critical DA-dependent aspect of feed-
enzyme in catecholamine biosynthesis, in dopaminergicing behavior.
neurons but can in noradrenergic neurons (Zhou and
Palmiter, 1995). DA2/2 mice are born normally but gradu-
ally stop nursing and die. These mice can be rescuedIntroduction
to adulthood with daily administration of L-DOPA, the
biosynthetic product of TH. This treatment causes themThe nigrostriatal, mesolimbic, and mesocortical path-
to become hyperactive for z6 hr and consume sufficientways are the major dopaminergic pathways within the
quantities of food and water to survive, but then theycentral nervous system (CNS). DA-producing cells in the
become inactive and stop eating until the next injection.substantia nigra (SN) and ventral tegmental area (VTA)
Analysis of brain catecholamines reveals that norepi-project topographically to specific brain regions, and
nephrine levels are normal, but DA concentrations onlydopamine (DA) released in these regions is postulated
reach 10% to 40% of wild-type levels at the peak of theirto regulate distinct behaviors (Koob, 1992; Self and Nes-
activity (1 hr following L-DOPA treatment) and graduallytler, 1995). For example, the nigrostriatal dopaminergic
decline to basal levels by 24 hr (Zhou and Palmiter,pathway, neurons that project from the SN to the stria-
1995; our unpublished data). When this daily regimen istum (caudate putamen), is thought to be intimately in-
terminated, DA2/2 mice stop eating and drinking, losevolved in the control of locomotion because selective
weight, and expire within 3 days of their last injection.6-hydroxydopamine (6-OHDA) or N-methyl-4-phenyl-
Surprisingly, they display locomotor activity between 241,2,3,6-tetrahydropyridine (MPTP) lesions of this path-
to 48 hr following L-DOPA removal that is equivalent toway in rodents and nonhuman primates result in defects
wild-type mice, but they eat very little (our unpublishedin initiation and coordination of locomotion (Ungerstedt,
data). This suggests that movement and feeding are1971; Langston et al., 1984; Kopin and Markey, 1988).
separable. The dopamine D1, D2, D3, and D4 receptorsIn addition, patients with Parkinson's disease exhibit
and the dopamine reuptake transporter (DAT) knockoutmotor defects such as tremors and difficulty in initiation
mice display locomotor deficits but do not exhibit seri-of locomotion that result from a gradual degeneration
ous feeding deficits (Drago at al., 1994; Xu et al., 1994;
Baik et al., 1995; Accili et al., 1996; Giros et al., 1996;³ To whom correspondence should be addressed (e-mail: palmiter@
Maldonado et al., 1997; Rubinstein et al., 1997; Xu etu.washington.edu).
al., 1997). Thus, unbalanced DA signaling affects loco-§ Present address: Wallenberg Neuroscience Center, Section of
Neurobiology, 17, S-223 62 Lund, Sweden. motion without disrupting food consumption.
Neuron
168
Several groups have recently demonstrated that re-
combinant adenovirus (rAd), adeno-associated viruses
(rAAV), and herpes simplex virus can transduce neurons
and glial cells in the CNS and promote ectopic gene
expression of TH in these cell types. TH expression
decreases apomorphine-induced rotational behavior
that occurs upon unilateral 6-OHDA destruction of nigro-
striatal neurons. This suggests that exogenous L-DOPA
production is able to partially ameliorate deficits that
occur with destruction of dopaminergic neurons (David-
son et al., 1993; During et al., 1994; Horellou et al., 1994;
Kaplitt et al., 1994).
Here, we report that coinjection of two rAAVs express-
ing either human TH or GTP cyclohydrolase 1 (GTPCH1)
rescues the lethality of DA2/2 mice by selectively restor-
ing feeding behavior to previously aphagic DA2/2 mice.
These viruses were injected into brain regions contain-
ing projection fields of dopaminergic neurons. GTPCH1
is the rate-limiting enzyme in the synthesis of tetrahy-
drobiopterin (BH4), an essential cofactor for TH function
(Nichol et al., 1985; Levine et al., 1990). It is expressed
preferentially in cells that produce monoamines or nitric
Figure 1. Viral Gene Therapy Promotes Survival of DA2/2 Miceoxide (Lentz and Kapatos, 1996). Thus, GTPCH1 virus
DA2/2 mice were injected with two rAAV vectors expressing eitherwas included because neurons and glia in the projection
human TH or human GTPCH1, and survival was monitored afterfields were not expected to have adequate BH4. Previ-
removal of L-DOPA. Three groups were generated via bilateral direct
ous experiments with 6-OHDA lesioned rats indicated injection; mix (rAAV-TH 1 rAAV-GTPCH1), TH (rAAV-TH), and
that both rAAV-TH and rAAV-GTPCH1 were required for GTPCH1 (rAAV-GTPCH1). L-DOPA was removed 7 days following
efficient L-DOPA production (Mandel et al., 1998). We surgery. Food consumption and body weight measurements were
recorded daily as criteria for survival. Mice that lost .20% bodyhave used this approach to begin to map where DA
weight in 3 days and looked moribund were considered as nonsur-acts in the brain to influence locomotor and feeding
vivors.
behaviors. (A) Survival following termination of L-DOPA treatment 7 days post-
surgery.
(B) Survival following termination of L-DOPA treatment 2 months
postsurgery.Results
Coinjection of rAAV Expressing Human TH
and GTPCH1 Rescues the Lethality
of DA2/2 Mice with L-DOPA removal 2 months following surgery sur-
Recombinant AAV engineered to express either human vived for 2 weeks before they were sacrificed (Figure 1B).
TH (rAAV-TH) or GTPCH1 (rAAV-GTPCH1) were injected None of the GTPCH1 group survived with this challenge.
bilaterally into the ventral caudate putamen of adult Because BH4 appears to be required for L-DOPA pro-
DA2/2 mice. Groups of mice were generated via direct duction in rescued mice, we attempted to stimulate
injection of rAAV expressing TH alone, GTPCH1 alone, feeding in the TH alone group with intraperitoneal injec-
or a 1:1 mixture of the two viruses (designated as mixed tions of either BH4 or a more stable methylated deriva-
vector). Because gene expression from transgenic rAAV tive, DL-6-methyl-5,6,7,8-tetrahydropterine (PH4). Sev-
is delayed for several days after viral transduction, daily eral concentrations (25, 50, and 100 mg/kg body weight)
L-DOPA treatment was continued for 6 to 7 days after of both drugs were tested, but none were successful at
viral delivery to allow for expression of TH and GTPCH1 stimulating feeding over a 2 hr period (data not shown).
(Kessler et al., 1996; Miao et al., 1998). Then the ability Because an effective concentration of BH4 or PH4
to survive without L-DOPA treatment was assessed by reaching the brain was not achieved with a single injec-
monitoring food intake and body weight. Mice that con- tion, we also attempted to reach a therapeutic dose by
sumed greater than 50 g/kg body weight and lost less using an osmotic minipump delivering a solution of PH4
than 20% of their starting body weight were monitored at a rate of 100 mg/kg/hr over 7 days. Minipumps were
for an additional 24 hr without L-DOPA treatment. To implanted into a subset of the TH alone group (n 5
avoid casualties, animals below this threshold were kept 4), but this treatment was also ineffective at promoting
alive with daily L-DOPA treatment and were tested for survival when L-DOPA was removed (data not shown).
survival at regular intervals thereafter. Most of the mixed
vector group (20 of 23 injected mice) survived when
Feeding Behavior of Rescued DA2/2 MiceL-DOPA was removed 7 days following surgery; how-
On the first day after L-DOPA removal, the averageever, neither the TH nor GTPCH1 groups met the above
amount of food ingested by the mixed vector groupcriteria and were, therefore, treated with L-DOPA (Figure
1A). A few of the TH alone group (three of ten) challenged (65 6 11.2 g/kg body weight) was greater than quantities
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Figure 3. Ambulatory Activity and Coordinated Locomotion of Wild-
Type, DA2/2, and Virally Rescued Mice
(A) Activity of wild-type (n 5 8), DA2/2 (n 5 17), and virally rescued
mice (TH, n 5 3; Mix, n 5 20) was monitored over a 24 hr period in
an activity chamber. *p , 0.05 compared to wild-type and DA2/2
mice assessed 24 to 48 hr after their last L-DOPA injection.
(B) Time spent on a rotarod by wild-type (n 5 15), DA2/2 (n 5 15),
and virally rescued mice (TH, n 5 3; Mix, n 5 20). *p , 0.05 compared
to wild-type mice.
quantities of food that were similar to the mixed vector
group on the first day following L-DOPA removal. There-
after, they began to eat less than the mixed vector group
(Figure 2A). However, the amount of food consumed
was significantly greater than GTPCH1 injected mice or
untreated DA2/2 mice monitored 24 to 48 hr following
their last L-DOPA injection (Figure 2B).
Body weight measurements were consistent with food
Figure 2. Food Intake and Body Weight Measurements of Virally
intake (Figure 2C). The initial weight loss in the mixedTransduced DA2/2 Mice following Termination of L-DOPA Treatment
vector group was followed by a rebound in body weight
(A) Daily food intake of mice injected with rAAV-TH 1 rAAV-GTPCH1
that exceeded their body weight on the day of the sur-(mix), rAAV-TH alone (TH), and rAAV-GTPCH1 alone (GTPCH1) was
gery. Three of mixed vector group mice have been moni-monitored following removal of L-DOPA. Average food consumption
by wild-type and DA2/2 mice are indicated by dotted lines. Nonsurvi- tored for survival without L-DOPA treatment for 13
vors are indicated by the cross. months, and they continued to consume sufficient quan-
(B) Comparison of daily food intake of wild-type (WT), DA2/2, and tities of food for survival and maintenance of body
virally transduced mice (TH, Mix, and GTPCH1) averaged over a weight. The partially rescued TH alone mice (n 5 3),
period of a week. *p , 0.05 compared with DA2/2 mice and **p ,
lost z18% of their body weight during the first 2 days,0.05 compared with wild-type and mixed vector mice (one way
maintained that weight for a few days, but then graduallyANOVA followed by Post Hoc analysis).
(C) Body weight measurements of virally transduced mice. lost more weight (Figure 2C). The experiment was termi-
nated because of their weight loss, unkempt appear-
ance, and shakiness.
consumed by DA2/2 mice removed from L-DOPA treat-
ment but was less than wild-type mice (Figure 2A). The Ambulatory and Motor Activity in Rescued Mice
In the process of monitoring food intake and body24 hr food consumption increased over the next 7 days,
and by the end of the week, 87% of the mixed vector weight, we noticed that most rescued mice were inactive
at the time of data collection regardless of whether mea-group (20 of 23 mice injected) consumed quantities of
food that were equivalent to wild-type mice. Beginning surements were taken during the light or dark cycle.
Therefore, we measured their ambulatory activity overat z2 weeks following removal of L-DOPA, their food
consumption fell to z80% of wild-type levels, but all 24 hr (Figure 3A). The ambulatory activity of rescued
mice (mixed vector, n 5 20; TH alone, n 5 3) was signifi-the mice appeared healthy, and their body weights con-
tinued to increase (Figure 2C). cantly lower than that observed in wild-type mice (n 5
8) and DA2/2 mice 24 to 48 hr following removal ofOnly 30% of the TH alone group challenged with
L-DOPA removal 2 months following surgery consumed L-DOPA (n 5 17). Although the majority of mixed vector
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g/kg body weight, saline 5 31 6 11.3 g/kg body weight).
However, when rescued mice were given L-DOPA, they
traveled z100 times farther than when they were treated
with saline.
Unilateral Injection of the Mixed Vector Causes
Rotational Behavior but Does Not
Rescue Feeding
We also attempted to rescue DA2/2 mice by unilaterally
injecting the mixed vector at identical coordinates into
the right hemisphere of the brain (n 5 5). None of these
animals consumed enough food to survive when L-DOPA
Figure 4. Activity Measurements of DA2/2 and Virally Rescued Mice treatment was terminated, and therefore, they were
Treated with L-DOPA maintained with daily injections (data not shown). Inter-
DA2/2 (n 5 17) and rescued mice (Mix, n 5 15; TH, n 5 3) were estingly, two weeks after viral injection, we noticed that
placed in an activity chamber and allowed to acclimate to the envi- all surviving animals exhibited spontaneous rotational
ronment for 24 hr. Mice were then injected with L-DOPA (50 mg/ behavior 21 hr following L-DOPA treatment that was
kg body weight) or saline, and ambulations and food intake were
exclusively to the left, which was counterclockwise frommonitored for 5 hr following administration of L-DOPA. Average ac-
the site of injection (Figure 5A). This rotational behaviortivity of wild-type mice is indicated by dotted line; they do not
respond to L-DOPA treatment. of unilaterally injected mice persisted until the experi-
ment was terminated (23 days after surgery). Treatment
with L-DOPA produced clockwise rotations and in-mice traveled less than 30 m/day, a large range of activ-
creased the number of turns (Figure 5B). In some casesity was observed (5.5 to 78 m/day). In fact, one of the
(mice #23 and #24), the rotational behavior switchedmixed vector group displayed ambulatory activity (78
completely from counterclockwise (21 hr following theirm/day) that was similar to the least active wild-type
last injection) to clockwise (1 hr following injection). Aftermouse tested (70 m/24 hr). The distances traveled in 24
2 hr, rotational behavior evened out, with most animalshr by the mixed vector and TH alone groups were also
exhibiting rotations in both directions (Figure 5C).lower than those traveled by DA2/2 mice monitored 24
to 48 hr following their last injection of L-DOPA. This is
because DA2/2 mice exhibit a DA-independent wave of TH Immunohistochemistry Reveals Differences
in Anatomical Distribution between Mixedactivity that occurs during this time (our unpublished
data). Vector and rAAV-TH Alone Groups
TH immunohistochemistry was performed to determineDuring routine handling, rescued mice exhibited defi-
cits in initiation and coordination of motor movement the extent of viral transduction and to ascertain if behav-
ioral differences between groups could be attributed tothat were similar to DA2/2 mice 24 hr after removal of
L-DOPA. Thus, to examine coordinated motor activity, variation in TH expression. With the exception of the
locus ceruleus, endogenous TH is not synthesized withinthe performance of the mice on a rotating wheel (rotarod)
was examined. Wild-type mice perform the rotarod task the brains of DA2/2 mice, and therefore, TH antibody
could be used to identify areas that were virally trans-reasonably well, staying on the rod for an average of 47
s during a 90 s trial (Figure 3B). The mixed vector group duced. Sections 20 mm thick were cut from the brains
of virally injected DA2/2 mice, and multiple sectionsand the TH alone group were deficient in this test but
were better than DA2/2 mice tested 24 hr following their (spaced z100 mm apart) surrounding the injection site
and encompassing the majority of the brain were probedlast injection of L-DOPA.
with TH antibody. Low-powered views of three repre-
sentative coronal sections from a mixed vector mouseRescued Mice Exhibit Increased Locomotion
with L-DOPA Treatment (designated as 18 in Figure 7) rescued for feeding but
not locomotion are shown in Figures 6A±6C). Note ex-L-DOPA treatment of DA2/2 mice results in hyperactivity
that lasts for z6 hr following drug administration (Zhou tensive TH staining indicated by arrows within the cau-
date putamen (CPu) but also within ventral structures inand Palmiter, 1995). Because deficiencies in ambulatory
activity and coordinated locomotion were observed in the brain (marked with arrowheads). Additional staining
was also detected in posterior brain regions (Figure 6C).rescued mice, we asked whether they would respond
to L-DOPA treatment. Rescued mice were habituated in A higher magnification view of one of the anterior brain
regions (0.9 mm bregma) depicting TH staining withinactivity chambers for 24 hr and then injected with a
standard dose of L-DOPA or saline, and their ambulatory ventral structures is shown in Figure 6D. Cell bodies and
fibers stained with TH antibody can be visualized underactivity and food intake were monitored for 5 hr following
treatment. Ambulatory activity increased significantly higher magnification within the insular (Ins), dorsal en-
dopiriform (DEn), and piriform (Pir) corticies (Figures 6Efollowing L-DOPA treatment, peaked at 2 hr, and gradu-
ally declined so that by 5 hr, activity was nearly back and 6F). This is the typical pattern of staining observed
in TH-positive areas; however, regions where only fibersto basal levels (Figure 4). The magnitude of this increase
was less than that observed after treatment of DA2/2 exhibited staining were also observed (Figure 6G). These
fiber-containing regions were routinely found in corticalmice with L-DOPA, but the duration of the effect was
identical. A slight increase in feeding over the 5 hr period areas dorsal and lateral to regions that exhibited intense
TH staining. The specific nature of this staining waswas observed with L-DOPA treatment (L-DOPA 5 64 6
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Figure 5. Rotational Behavior of DA2/2 Mice
Injected Unilaterally with Mixed Vector
Unilaterally injected mice (n 5 4) were treated
with L-DOPA (50 mg/kg body weight ) and
returned to their homecage, and their activity
over 15 min was videotaped at 1, 2, and 21
hr following treatment. The number of 3608
clockwise or counterclockwise turns that oc-
curred during these intervals was counted.
confirmed in unilaterally injected mice because cortical mouse are shown in green and red. Because bilateral
transduction in ventral structures correlates with rescue,fiber staining was only observed on the side of the brain
where rAAV-TH was injected. GTPCH1 immunostaining these regions are shown in red. TH was detected in the
CPu and in ventral brain structures of all rescued andrevealed a pattern that overlapped with TH expres-
sion. An example of this overlap is shown in Figures 6H partially rescued mice (Figure 7, TH 1 GTPCH1, mice
#17, #18, #19, and #57 and TH alone, mice #1, #4, andand 6I.
Regions exhibiting TH immunoreactivity in rAAV-TH #5). The anterior-most brain region (bregma, 0.9 mm)
consistently exhibited TH staining in ventral structuresalone and mixed vector mice are summarized in Figure 7.
These overlays were created by systematically mapping including several cortical areas. Analysis of a more pos-
terior brain region (bregma, 0.3 mm) also revealed stain-TH-positive regions within coronal sections of virally
transduced mice. Brain regions described in this study ing in ventral brain regions of rescued mice, notably,
the ventral pallidum (VP), olfactory tubercle (Tu), andare shown in the color-coded diagrams in the top panel
of Figure 7. Regions transduced by rAAVTH in each medial preoptic area (MCPO). The mixed vector mice
Figure 6. TH Immunohistochemistry in Various Brain Regions of Virally Transduced DA2/2 Mice
(A±C) Low-powered view of TH immunostaining in coronal sections of a rescued mouse transduced with rAAV-TH 1 rAAVGTPCH1 (Mouse
#18, Figure 7). Arrows denote TH-positive areas within dorsal structures, and arrowheads demarcate TH staining in ventral structures.
(D) A high-powered view of boxed area in (A) shows TH immunostaining within ventral brain structures. TH-positive brain regions include the
insular (Ins), dorsal endopiriform (DEn), and Piriform (Pir) corticies. Other areas of interest that are not stained include the lateral shell (LshNAc)
and core (NAc) of the nucleus accumbens; bar represents 500 mm.
(E and F) TH staining of cell bodies and fibers within the DEn (upper box from [D]), and Pir (lower box from [D]); bar 5 100 mm.
(G) A high-power view of TH-positive fibers found within the dorsal neocortex of a rescued mouse; bar 5 100 mm.
(H) TH immunostaining within the CPu of a mouse transduced with mixed virus (mouse #17 in Figure 7); bar 5 500 mm.
(I) GTPCH1 immunostaining in an adjacent section from mouse #17 demonstrates a similar pattern of GTPCH1 expression; bar 5 500 mm.
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Figure 7. Mapping of TH-Positive Areas in Virally Transduced Mice
A color-coded key to various brain regions depicted in these sections is shown at top of left panel. Below are shown analyses of six mice
treated with mixed virus. Right panel shows analysis of seven mice treated with rAAV-TH alone. Free-floating coronal sections spaced at 100
mm intervals and encompassing the entire brain were stained with TH antibody, and TH-positive areas were identified with a microscope
under low magnification. Putative areas were then viewed under higher power to verify the presence of cell bodies. Regions containing cell
bodies were scored as positive and are shown in green (dorsal structures) and red (ventral structures). Values for activity are reported in
meters traveled over 24 hr (nd 5 not determined). Open boxes denote virally transduced mice that were not rescued for feeding, partially
filled boxes represent partial rescue of feeding, and filled boxes full rescue. Diagrams of coronal sections were modified from Franklin and
Paxinos (1997).
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also exhibited TH staining in the other posterior brain Discussion
regions (-1.0 mm bregma) that did not appear in any of
the TH alone group including the partially rescued mice. Dopamine signaling in the CNS affects locomotion, neu-
roendocrine secretion, cognition, feeding, and reward-Within this region, TH staining was observed in the lat-
eral globus pallidus (LGP), amygdala (Amg), and the related behaviors. Pharmacology and electrophysiology
experiments have begun to identify specific dopaminer-reticular thalamus (RT). Although TH staining was de-
tected within the CPu of nonrescued mice, none was gic pathways responsible for the regulation these dis-
tinct processes. It has been demonstrated that DA playsdetected in either ventral or posterior brain regions.
Feeding was not restored in a few mice that received a role in regulating locomotion through its connections
to the basal ganglia, and experimental evidence sug-bilateral injections of mixed vector or in any of the mice
that were unilaterally injected (Figure 7, mice #10 and gests that the mesolimbic dopaminergic pathway is in-
volved in regulating other behaviors including drug self#15). Presumably, critical brain regions were not trans-
duced in these mice. Bilateral TH staining was observed administration. However, the extent to which these be-
haviors are attributable to these distinct pathways is notin the anterior CPu of one of the bilaterally injected
nonrescued mice (mouse #10), but not in ventral or pos- clear.
Although DA is known to regulate a number of behav-terior brain nuclei. Another bilaterally injected mouse
(mouse #15) also exhibited bilateral TH staining in the iors, its role in feeding is less certain. Anand and Brobeck
(1951) found that electrolytic lesions of the lateral hypo-anterior CPu, but not within ventral (Ins, VP, DEn, and
Pir) regions and only unilaterally within posterior (LGP, thalamus (LH) caused aphagia, suggesting that this
brain region is involved in the control of feeding behav-RT, and Amg) brain regions. The anterior to posterior
pattern of TH immunostaining observed on the right side ior. The coincident loss of ingestive behavior and deple-
tion of catecholamines in the LH suggested that DAof three of five unilaterally injected mice was similar to
that observed in most bilaterally injected mice (data not might function to stimulate feeding. Destruction of dopa-
minergic neurons that pass through the LH with 6-OHDAshown). In general, the distribution of TH immunostain-
ing in the mixed vector group was greater than that in adult rats initially confirmed this hypothesis (Unger-
stedt, 1971; Fibiger et al., 1973). However, subsequentobserved in the TH alone group, but TH was observed
in cell bodies and dendritic processes of both groups. studies with this model suggested that the aphagia
might result from nonspecific sensorimotor deficits
rather than a suppressive effect on feeding caused by
Catecholamine Measurements Correlate DA depletion (Salamone et al., 1990).
with TH Immunostaining Pharmacological experiments point to an inhibitory
Catecholamine measurements were performed on 2 mm or stimulatory role of DA in feeding, depending on the
diameter punches taken from 2 mm thick coronal sec- location of DA delivery. For example, chronic bilateral
tions of brains from mice injected with TH alone or mixed infusion of DA into the LH of obese Zucker rats de-
virus. Three samples, designated as anterior, posterior, creased meal size and promoted weight loss (Yang et
and midbrain, were obtained from each mouse. The al., 1997). Likewise, injection of amphetamine or DA ago-
anterior punch contained most of CPu and NAc, the nists into the LH inhibited fast-induced feeding by rats
posterior punch contained the tail end of the CPu, LGP, (Leibowitz and Brown, 1980). However, DA release in
and the entire amygdala, and the midbrain punch con- the shell of the nucleus accumbens (NAc) correlates
tained the substantia nigra. DA was detected in the with increased feeding behavior (Heffner et al., 1980;
anterior CPu (DA 5 298.1 6 36.2 ng/mg protein), poste- Hoebel et al., 1989). Furthermore, low doses of DA or DA
rior brain nuclei (DA 5 28.4 6 4.9 ng/mg protein), and agonists injected into the NAc or CPu stimulate feeding
substantia nigra (DA 5 14.5 6 1.4 ng/mg protein) of (Winn et al., 1982; Swanson et al., 1997; Taber and Fibi-
wild-type mice, but none was detected in DA2/2mice. ger, 1997). Microdialysis experiments demonstrate that
DA content in the CPu of the mixed vector group (n 5 DA release and turnover are increased in the NAc during
5) was 24% of wild-type levels, and the TH alone group feeding. Extracellular DA and its metabolites are in-
(n 5 5) was 5.8% of wild-type levels in this brain region. creased in anticipation of a meal, in response to presen-
DA was also present in the posterior brain regions of all tation of food and during ingestive behavior (Hoebel et
mixed vector mice (36% of wild type) but was undetect- al., 1992; Wilson et al., 1995; Martel and Fantino, 1996b).
able in the TH alone group. In addition, DA was detected This suggests that DA release in the NAc may play a
in the substantia nigra of one mixed vector mouse (77% direct role in stimulating ingestive behavior; however,
of wild type). These results support the conclusion that other brain regions innervated by dopaminergic neurons
differential TH expression and subsequent production might also be involved. In particular, the amygdala and
of DA from L-DOPA is responsible for the behavioral insular cortex have been implicated in the regulation of
differences observed between the two groups. taste-motivated behaviors and the acquisition of taste
The DOPAC/DA ratio, which is an index of DA turnover (Mogenson and Wu, 1982; Fernandez-Ruiz et al., 1993).
rate, was 0.09 in wild-type mice, 0.118 in the mixed We have previously shown that DA2/2 mice are apha-
vector group, but was 0.283 in the TH alone group, gic and expire at 2 to 4 weeks of age without treatment
indicating that turnover was elevated in the TH alone but can be kept alive by daily L-DOPA injections (Zhou
group. Thus, both DA content and turnover rates were and Palmiter, 1995). By 9 hr after their last injection with
closer to wild-type values in the mixed vector group, L-DOPA, they cease to eat enough to maintain body
which is consistent with the behavioral differences ob- weight even though they are able to run, jump, and climb
on cage tops in a fashion that is quantitatively similarserved between the two groups.
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to wild-type mice (our unpublished data). The DA2/2 levels of DAT, which would facilitate DA uptake into
dopaminergic neurons (our unpublished data). Further-mice grasp chow pellets and ingest small amounts of
food during the second day following L-DOPA treatment, more, the DOPAC/DA ratio in rescued mice is similar to
wild-type mice, suggesting that normal DA metabolismbut they do not continue to eat even though they are
nutritionally deprived. These observations suggest that has been established. It is also possible that some dopa-
minergic neurons are transduced through their axonsDA2/2 mice possess the motor capabilities to eat, but
they lack a drive to initiate and maintain feeding and and that the viral DNA is transported retrogradely to the
cell bodies where it is transcribed. In this case, rAAVthus terminate feeding prematurely.
expressing TH alone would be sufficient. The fact that
the mixed vector was much more effective at rescuing
Mechanism of Gene Therapy in DA2/2 Mice DA2/2 mice than rAAV-TH expressing TH alone argues
In wild-type animals, L-DOPA is synthesized from tyro- that this is not the major mechanism involved, but it may
sine in dopaminergic neurons by action of TH and then contribute.
converted to DA by L-aromatic amino acid decarboxyl-
ase (L-AADC). DA is transported into synaptic vesicles
by a vesicular transporter (VMAT2) and released upon Separate Dopaminergic Pathways Contribute
to Feeding and Locomotionneuronal excitation. Extracellular DA is then cleared
from the synaptic cleft by transport into presynaptic Coinjection of TH and GTPCH1 vectors into DA2/2 mice
fully rescued ingestive behaviors in most of the mice, butterminals via the DAT. Inactivation of the TH gene in
dopaminergic neurons precludes L-DOPA biosynthesis, activity and coordinated movement were only partially
restored. Rescued mice exhibited decreased ambula-but it does not appear to affect survival of dopaminergic
neurons, their ability to innervate the CPu, or the ability tory activity and performed at suboptimal levels on a
rotating wheel (Figure 3B) and in a pole climbing testof postsynaptic neurons in the CPu to synthesize char-
acteristic marker proteins (Zhou and Palmiter, 1995). (Ogawa et al., 1985; our unpublished results). In addition
to these deficits, rescued mice also display deficienciesThus, unlike 6-OHDA-lesioned models, dopaminergic
terminals are distributed normally in DA2/2 mice, but in nest building behavior (Aubert et al., 1997; Sherwin,
1997; M. S. S. and R. D. P., unpublished data). Takenthey cannot synthesize or release DA unless L-DOPA is
provided. For routine maintenance of these mice, together, these three tests demonstrate that not only is
coordinated behavior compromised (rotarod and poleL-DOPA is provided daily by intraperitoneal injection.
L-DOPA readily crosses the blood±brain barrier and is climbing) but also certain aspects of motivated behavior
(nest building). Analysis of TH expression in the micepresumably taken up by all cells via amino acid trans-
porters. All cells that express L-AADC would be able that were and were not rescued by the mixed virus,
as well as the nonrescued mice injected with rAAV-to convert it to DA (this would include all monoamine-
producing cells), and those cells that express VMAT2 TH alone, indicate that bilateral transduction of cells
in ventral brain regions is critical for normal feeding.would be able to package and release the DA. After
release, DA could be taken up by dopaminergic termi- Although the shell of the NAc has been implicated in
feeding by other techniques (Maldonado-Irizarry et al.,nals via the DAT. DA is also readily metabolized by
monoamine oxidases and catecholamine methyl trans- 1995), we did not observe high levels of TH expression
within this nucleus. Instead, we detected extensive bilat-ferase; thus, after a single injection of L-DOPA, DA levels
peak at about 1 hr and decline to barely detectable eral transduction in regions ventral and lateral to the
NAc. It is possible that DA diffuses a short distance tolevels 9 hr later.
Our strategy was to inject the rAAVs into the projection the NAc or that neuronal projections of virally trans-
duced cells project to the NAc and release DA, but closefields of dopaminergic neurons in the ventral CPu and
NAc. The most likely scenario for rescue is that nondo- analysis of the NAc of rescued mice did not reveal TH-
immunoreactive fibers.paminergic neurons at the site of injections are trans-
duced by rAAV. Most of the cells probably do not ex- Our data indicate that cotransduction with TH and
GTPCH1 is essential for early and prolonged rescue.press GTPCH1; thus, with rAAV-TH alone, these cells
probably rely on subthreshold levels of BH4, and conse- GTPCH1 not only provides an essential cofactor for en-
zymatic activity but may also stabilize TH against degra-quently, they would synthesize very little L-DOPA.
It is readily apparent that TH immunoreactivity in the dation. The fact that GTPCH1 is required indicates that
most of the transduced cells are not capable of makingCPu is within cells with cell bodies and projections that
resemble neurons. They are most likely medium spiny adequate BH4. Surprisingly, none of our attempts to
supply BH4 peripherally were able to restore feeding inGABAergic neurons because they are the most abun-
dant neurons in this region, but various interneurons are mice transduced with rAAV-TH only. Thus, the mixed
vector approach (Mandel et al., 1998), or bicistronic ex-probably also transduced. These cells would not be
expected to have either L-AADC or VMAT2; therefore, pression vectors, are likely to be more effective as possi-
ble treatments of humans with DA deficiencies.we suspect that the L-DOPA they produce (or DA if they
have L-AADC) crosses the plasma membrane and is Although most DA2/2 mice treated with the mixed
virus eat enough to gain and maintain body weight,taken up by dopaminergic terminals in the vicinity, pack-
aged into vesicles, and released appropriately. We spec- they do not display normal motor behaviors. There are
several possible explanations for these observations.ulate that diffusion of L-DOPA and/or DA released by
these cells is limited because dopaminergic neurons This might be expected if restoration of feeding requires
less DA than restoration of movement. However, lowerthat project to virally transduced regions contain normal
Neuron
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modifications. The helper plasmid pUC19.ACG was used to supplydoses of L-DOPA are required to restore locomotion
AAV rep and cap functions. This construct harbors the XbaI fragmentthan feeding in DA2/2 mice. This may reflect supersensi-
of pACG2±1 described by Li et al. (1997), which was isolated bytivity of pathways specifically required for locomotor
PCR to change the 59 XbaI site to HindIII and the 39 XbaI site to
behavior (our unpublished data). Another possibility is BamHI. This fragment was inserted into the HindIII and BamHI sites
that a subpopulation of neurons in DA2/2 mice are af- in pUC19; it does not harbor the adenoviral terminal repeats. rAAV
fected by development in the absence of DA. These virions were purified on two sequential isopycnic CsCl gradients
formed in a Beckman NVT65 rotor at 60,000 rpm for 6 hr minimum,changes might preclude the ability to restore movement
and fractions were collected using a Beckman Fraction Recoveryand coordinated behavior to wild-type levels even if DA
System. Following CsCl banding, the fractions containing rAAV wereis replaced in critical brain regions at appropriate levels.
dialyzed against PBS. The vector preparations had particle titersHowever, a range of locomotor activity was observed
between 1011±1012/ml. Wild-type AAV contamination was less than
in mice that exhibited total rescue of feeding behavior, 2 particles/108 particles, and there was no contaminating infectious
and one mouse displayed motor activity that was similar adenovirus.
to wild-type mice. Yet another possibility is that dopa-
minergic projection fields involved in feeding are distinct Intracerebral Injection of Recombinant AAV Vectors
Mice were placed in a stereotax (Kopf), and the head was leveledfrom those involved in movement. Many previous stud-
in the x, y, and z planes using the sagittal suture and lambda andies have suggested that the dorsal lateral striatum and
bregma as landmarks. Recombinant AAV vectors in PBS were in-its direct and indirect output pathways are involved in
jected into ventral striatum (0.8 anterior-posterior, 2.2 and 22.2
locomotion, whereas the ventral striatum is involved in medial-lateral, and 3.6 dorsal-ventral using bregma as the reference
directing motivated behaviors (Kopin and Markey, 1988; point [Slotnick and Leonard, 1975]). Virus (2 ml) was injected through
Wise and Hoffman, 1992). In most of the mice treated a 5 ml Hamilton syringe fitted with a 30 gauge needle at a rate of
with the mixed vector, TH expression was prominent in 0.5 ml/min. Injection rate was controlled using a KD scientific infusion
pump. Following each 4 min injection, the needle remained station-ventral structures of the anterior brain and also in more
ary for an additional 4 min and was then raised 0.5 mm and main-caudal brain nuclei (Figure 7). Depletion of DA results
tained in this position for an additional 2 min before being removed.in a locomotor supersensitivity that is revealed upon
Injections were performed sequentially into the right and left sides
activation of DA receptors (Ungerstedt, 1971). The ob- at identical coordinates. DA2/2 mice were injected bilaterally with
servation that supersensitivity persists but is attenuated 2 ml of: rAAV-TH (n 5 23), rAAV-GTPCH1 (n 5 5), or a 1:1 mixture
in rescued mice, argues that DA has not been restored of rAAV-TH and rAAV-GTPCH1 (n 5 23). An additional four mice
were injected unilaterally with 2 ml of the mixed virus (n 5 4).to normal levels in brain regions that control locomotion.
One mouse that was not rescued for feeding by the
Behavioral Analysismixed virus was incredibly active (mouse #15). Subse-
Ambulatory activity of wild-type or rescued mice was measured inquent analysis revealed bilateral TH expression in the
transparent plexiglass cages (40 3 20 3 20 cm) placed into andorsal regions of the caudate putamen. Thus, we favor
activity chamber equipped with infrared beams (San Diego Instru-
the idea that the sites of viral integration and the location ments Inc.). The number of consecutive beam breaks that occurred
of local L-DOPA production are determinants of behav- each hour during a 48 hr period was measured and converted to
ioral correction. Consequently, with more refined place- meters using the distance between beams (8.8 cm) as a conversion
factor. Response of DA2/2 and rescued mice to L-DOPA was moni-ment and more restricted areas of transduction, it should
tored as above after they were allowed to habituate for 24 hr. Activitybe possible to delineate more precisely specific brain
was monitored for 1 hr, and then they were injected with either 50regions responsible for various DA-mediated behaviors.
mg/kg L-DOPA (dissolved in PBS) or PBS, and their activity andThis does not preclude the possibility of L-DOPA pro-
food intake were monitored over the next 5 hr. Rotarod experiments
duction affecting several behaviors. were performed with Jones and Roberts apparatus (Rod diameter 5
We have demonstrated that gene therapy rescues the 4 cm). Wild-type (n 5 16), DA2/2 (n 5 10), TH alone (n 5 3), and
aphagia of DA2/2 mice and presented evidence of a mixed vector mice (n 5 13) were placed on a rotarod for 1 min. The
rotarod was accelerated to a speed of 10 RPM over z40 s and waspartial separation of movement and feeding. These data
maintained at 10 RPM for an additional 50 s. Each animal was trainedsuggest that this technique can be used to map dopa-
four times; the time spent on the rod during the 4th trial is reported.minergic pathways that specifically regulate feeding and
Activity and rotarod measurements were performed 3 to 5 days andmovement. Application of this technique provides a new
2 months following removal of L-DOPA.
approach to identify dopaminergic pathways that are Rotational behavior of unilaterally injected mice (n 5 4) was quan-
required for specific behaviors. Furthermore, this work titated following L-DOPA treatment. Mice were injected with 50 mg/
demonstrates that rAAV-based gene therapy has poten- kg body weight of L-DOPA and returned to their homecages, and
then they were filmed for 15 min periods at 1, 2, and 21 hr followingtial application for the treatment of human Parkinson's
treatment. The number of 3608 turns that occurred during each 15disease.
min period in either the clockwise or counterclockwise directions
were tallied by viewing videotape of each mouse.Experimental Procedures
HistologyGeneration of DA2/2 Mice
TH and GTPCH1 immunohistochemistry were performed as follows.Mice were housed on a 12 hr light-dark cycle with the dark cycle
Mice were killed by CO2 inhalation, systemic blood was cleared byoccurring from 19:00 to 07:00. Food and water were provided ad
perfusion with PBS (PBS was 100 mM phosphate, 150 mM NaCllibitum. All injections were performed on 3- to 6-month-old DA2/2
[pH 7.0]), then mice were perfused with 4% paraformaldehyde inmice; they were third and fourth generation hybrids of 129 Sv/
PBS and postfixed overnight at 48C. Brains were sunk in 30% su-CPJ 3 C57BL/6J. All behavioral tests were performed during the
crose and frozen on dry ice. Sections (10±20 mm) were then cut onlight cycle. Genotype was confirmed by Southern blot analysis as
a freezing microtome and stored at 48C in PBS containing 0.1%described (Zhou and Palmiter, 1995).
azide. The following manipulations were performed at room temper-
ature. Free-floating sections were washed briefly in PBS containingRecombinant AAV Vector Production
0.1% Triton X-100 (PBS-TX) and then incubated for 20 min in PBS-Recombinant AAV vectors rAAV-TH, rAAV-GTPCH1, and rAAV-GFP
were prepared as described by Snyder et al. (1997) with the following TX 1 3% H2O2. Sections were rinsed in water, washed 3 times in
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PBS-TX (5 min each wash), and then incubated in PBS-TX containing Long-term behavioral recovery in parkinsonian rats by an HSV vector
expressing tyrosine hydroxylase. Science 266, 1399±1403.8% normal goat serum (NGS) for 1 hr to block nonspecific binding.
Sections were incubated for 15 to 24 hr in PBS-TX 1 1% NGS Fernandez-Ruiz, J., Miranda, M.I., Bermudez-Rattoni, F., and Drucker-
containing rabbit polyclonal TH antibody (Eugene Tech, 1:1000 dilu- Colin, R. (1993). Effects of catecholaminergic depletion of the amyg-
tion), washed 3 times in PBS-TX, and then incubated for 2 hr with dala and insular cortex on the potentiation of odor by taste aver-
biotinylated secondary antibody in PBS-TX 1 1% NGS (Vector Labo- sions. Behav. Neural. Biol. 3, 189±191.
ratories, 1:500). Sections were washed and stained for TH accord- Fibiger, H.C., Zis, A.P., and McGeer, E.G. (1973). Feeding and drink-
ing to standard streptoavidin immunohistochemical procedures. ing deficits after 6-hydroxydopamine administration in the rat: simi-
GTPCH1 immunohistochemistry was performed using identical con- larities to the lateral hypothalamic syndrome. Brain Res. 1, 135±148.
ditions. Primary antibody against GTPCH1 was used at a 1:3000
Franklin, K.B.J., and Paxinos, G. (1997). The Mouse Brain in Stereo-dilution (Mandel et al., 1998).
taxic Coordinates (New York: Academic Press).
Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., and Caron, M.G.Mapping TH Expression
(1996). Hyperlocomotion and indifference to cocaine and amphet-Anterior, posterior, medial, lateral, dorsal, and ventral regions re-
amine in mice lacking the dopamine transporter. Nature 379,ferred to in this study were designated as follows using the albino
606±612.mouse atlas as a guide for map coordinates (Slotnick and Leonard,
Hajnal, A., and Lenard, L. (1997). Feeding-related dopamine in the1975). Anterior is defined as an area extending from 1.3 to 20.7
amygdala of freely moving rats. Neuroreport 8, 2817±2820.with respect to bregma. Posterior is defined as an area encom-
passing from 20.7 to 22.7 with respect to bregma. The anterior Heffner, T.G., Hartman, J.A., and Seiden, L.S. (1980). Feeding in-
CPu is divided into medial-lateral and dorsoventral portions. Medial creases dopamine metabolism in the rat brain. Science 208, 1168±
extends from midline to a 2.2 mm distance from bregma, and lateral 1170.
was designated from 2.2 mm to the outer most portion of the brain Hoebel, B.G., Hernandez, L., Schwartz, D.H., Mark, G.P., and Hunter,
(z5.0 mm). Dorsal extends 2.2 mm from bregma, and ventral extends G.A. (1989). Microdialysis studies of brain norepinephrine, serotonin,
from 2.5 mm to the ventral most portion of the brain (z5.6 mm). and dopamine release during ingestive behavior. Theoretical and
clinical implications. Ann. N.Y. Acad. Sci. 575, 171±191.
Dopamine Content
Hoebel, B.G., Mark, G.P., and West, H.L. (1992). Conditioned release
The brains of five rescued (mixed vector), five nonrescued (rAAV-
of neurotransmitters as measured by microdialysis. Clin. Neurophar-
TH alone), two wild-type, and two DA2/2 mice were dissected into
macol. 15 (Suppl. 1), 704A-705A.
three regions, and 2 mm tissue punches were collected as above.
Horellou, P., Vigne, E., Castel, M.N., BarneÂ oud, P., Colin, P., Perri-Catecholamine content was determined as described (Mandel et
caudet, M., Delaere, P., and Mallet, J. (1994). Direct intracerebralal., 1998).
gene transfer of an adenoviral vector expressing tyrosine hydroxy-
lase in a rat model of Parkinson's disease. Neuroreport. 6, 49±53.
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